<DOC>
	<DOC>NCT01319318</DOC>
	<brief_summary>This study will evaluate the degree of post-operative ocular inflammation in patients who are undergoing a pars plana vitrectomy.</brief_summary>
	<brief_title>Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy</brief_title>
	<detailed_description />
	<mesh_term>Temazepam</mesh_term>
	<criteria>Require pars plana vitrectomy in at least 1 eye Best corrected visual acuity in the study eye between 20/400 and 20/40 Use of any NSAIDs (topical or systemic) within 14 days Use of topical or systemic steroids within 30 days Active eye infection in either eye Any eye surgery within 6 months Prior pars plana vitrectomy, YAG capsulotomy or uveitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>